ZERIA PHARMCEUTICAL CO., LTD.【JP:4559】Cash flow
Market cap
¥112.2B
P/E ratio
9.8x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 1,958 | 2,429 | 3,106 | 3,143 | 3,033 | 3,256 | 3,749 | 4,701 | 5,431 | 6,341 | 6,843 |
| Cash from operations | 653 | 5,695 | 7,238 | 8,822 | 5,501 | 7,251 | 6,894 | 8,951 | 13,157 | 12,184 | 12,922 |
| Capital expenditures | -1,793 | -2,335 | -1,673 | -1,785 | -1,089 | -622 | -734 | -1,064 | -2,400 | -2,901 | -1,429 |
| Cash from investing | 476 | -32,709 | -703 | 1,564 | -2,856 | -405 | -17,461 | -2,893 | -2,575 | -3,952 | -1,051 |
| Payments for dividends | -1,586 | -1,587 | -1,694 | -1,711 | -1,702 | -1,597 | -1,568 | -1,538 | -1,590 | -1,935 | -1,977 |
| Repurchases of common stock | -1 | -1 | -1 | -5,608 | -4,978 | -3,290 | -1,154 | -2,603 | -674 | -1 | -1 |
| Proceeds from issuance of term debt, net | 200 | 915 | - | 10,568 | 2,000 | 500 | 4,500 | 16,159 | 500 | 500 | 3,273 |
| Repayments of term debt | -2,687 | -2,709 | -7,620 | -3,014 | -3,323 | -2,667 | -3,121 | -3,388 | -5,629 | -5,778 | -8,515 |
| Cash from financing | -5,840 | 22,416 | -8,983 | -9,629 | -4,535 | -5,878 | 11,185 | -4,841 | -7,415 | -8,124 | -7,757 |